News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PEP news

Show

From To
PEP
HIV Post-Exposure Prophylaxis Often Prescribed for Anxiety, not Need

A retrospective review of HIV-1 post-exposure prophylaxis (PEP) finds it is often prescribed in response to patients' emotional stress rather than according to treatment guidelines.

Published
09 November 2018
From
MD Magazine
PEP
New York City's Hotline for HIV Exposure a Success, Study Finds

Post-exposure prophylaxis (PEP) is a proven way to prevent HIV transmission after a possible exposure. Though access to PEP has been spotty, a dial-in hotline program in New York City has helped qualified patients access PEP at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.

Published
23 October 2018
From
The Body Pro
PrEP
US doctors’ organisation endorses event-based PrEP for the first time

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP) as an alternative to daily dosing. The International

Published
19 September 2018
By
Gus Cairns
PrEP
Over 2,000 people in British Columbia are now prescribed on new life-saving HIV prevention drug

Strong numbers on the uptake of a new provincial government-funded drug program that significantly reduces the likelihood of HIV infection could have a major impact on BC’s growth rate of new cases of HIV.

Published
30 June 2018
From
Daily Hive
HIV prevention policy
New Zealand sees drop in people diagnosed with HIV

The number of people diagnosed with HIV in New Zealand has significantly dropped, according to the AIDS Epidemiology Group of Otago University. It has been the first time the number has decreased since 2011. Last year, 197 people were diagnosed, a drop of 46 compared to 2016 when 243 people were diagnosed with HIV. Dr Sue McAllister said despite the drop being encouraging, it was too early to determine whether the decline would be maintained.

Published
20 June 2018
From
1 News Now
PEP
Study finds high burden of psychosocial issues among PEP users

74% had at least one psychosocial issue, including depression and/or problematic drug or alcohol use. Furthermore, nearly half of participants had more than one issue.

Published
15 June 2018
From
CATIE
PEP
Activists Demand Gilead Rescind nPEP Patient Access Program's Once-Per-Lifetime Use Limit

Gilead Sciences is coming under fire from HIV/AIDS activist groups for a recent change to its patient assistance program (PAP), which has imposed a once-per-lifetime limit on access to Truvada (tenofovir/FTC) as part of non-occupational post-exposure prophylaxis (nPEP). While the company will undertake "hardship reviews" for subsequent prescriptions, the activists say the process is unclear and will create a significant barrier to access, especially since nPEP should be started within 72 hours of possible exposure to HIV.

Published
02 February 2018
From
The Body
People and personal stories
A gay man’s first experience of using PEP

In recent months I experienced something I never thought I’d have to deal with when I faced the possibility that I might have contracted HIV.

Published
30 January 2018
From
Metro
PrEP
Up to a quarter of HIV-negative gay men attending three English clinics used PrEP in the last year

A prospective cohort study of gay men attending three clinics in southern England – 56 Dean Street and Mortimer Market Centre in London and the Brighton &

Published
13 November 2017
By
Gus Cairns
PrEP
High HIV incidence from non-primary partners and low PEP and PrEP use seen in PARTNER study

HIV incidence among the HIV-negative gay men in the PARTNER 1 and 2 studies, due to sex with partners outside the main relationship, was high,

Published
08 November 2017
By
Gus Cairns
← First12345...10Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.